These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith AM, Jacques TS, Lundberg IE, Minetti C, Nennesmo I, Rushing EJ, Sallum AM, Sewry C, Pilkington CA, Holton JL, Wedderburn LR, UK Juvenile Dermatomyositis Research Group. Ann Rheum Dis; 2015 Jan; 74(1):204-10. PubMed ID: 24064003 [Abstract] [Full Text] [Related]
4. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, Salisbury S, Bean JA. Arthritis Rheum; 2007 Oct 15; 57(7):1183-91. PubMed ID: 17907236 [Abstract] [Full Text] [Related]
10. Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool. Dorph C, Nennesmo I, Lundberg IE. J Rheumatol; 2001 Jul 15; 28(7):1591-9. PubMed ID: 11469467 [Abstract] [Full Text] [Related]
11. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F, International Myositis and Clinical Studies Group (IMACS). Rheumatology (Oxford); 2004 Jan 15; 43(1):49-54. PubMed ID: 12867580 [Abstract] [Full Text] [Related]
12. Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study. Apaz MT, Saad-Magalhães C, Pistorio A, Ravelli A, de Oliveira Sato J, Marcantoni MB, Meiorin S, Filocamo G, Pilkington C, Maillard S, Al-Mayouf S, Prahalad S, Fasth A, Joos R, Schikler K, Mozolova D, Landgraf JM, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation. Arthritis Rheum; 2009 Apr 15; 61(4):509-17. PubMed ID: 19333974 [Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Grundtman C, Tham E, Ulfgren AK, Lundberg IE. Arthritis Rheum; 2008 Oct 15; 58(10):3224-38. PubMed ID: 18821695 [Abstract] [Full Text] [Related]
15. [Myositis disease activity tool in Chinese patients with polymyositis/dermatomyositis]. Shu XM, Ma L, Lu X, Xie Y, Wang GC. Zhonghua Yi Xue Za Zhi; 2011 May 24; 91(19):1328-30. PubMed ID: 21756759 [Abstract] [Full Text] [Related]
17. Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele. Fedczyna TO, Lutz J, Pachman LM. Clin Immunol; 2001 Aug 24; 100(2):236-9. PubMed ID: 11465953 [Abstract] [Full Text] [Related]
18. Study of subcutaneous fat in children with juvenile dermatomyositis. Verma S, Singh S, Bhalla AK, Khullar M. Arthritis Rheum; 2006 Aug 15; 55(4):564-8. PubMed ID: 16874777 [Abstract] [Full Text] [Related]